# Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery

> **NCT03574311** · PHASE4 · UNKNOWN · sponsor: **Turku University Hospital** · enrollment: 210 (estimated)

## Conditions studied

- Coronary Artery Disease
- Postoperative Complications
- Aortic Valve Stenosis
- Mitral Valve Disease
- Aortic Aneurysm, Thoracic

## Interventions

- **DRUG:** Ferric carboxymaltose
- **OTHER:** Physiological saline

## Key facts

- **NCT ID:** NCT03574311
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-10-02
- **Primary completion:** 2022-12
- **Final completion:** 2023-12
- **Target enrollment:** 210 (ESTIMATED)
- **Last updated:** 2021-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03574311

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03574311, "Preoperative Intravenous Ferric Carboxymaltose and Placebo in the Treatment of Patients Undergoing Cardiac Surgery". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03574311. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*